PT1166773E - Solucao de tetra-hidrato do sal monossodico da n-o(p-pivaloiloxibenzenossulfonilamino)benzoilglicina e seu produto farmaceutico - Google Patents
Solucao de tetra-hidrato do sal monossodico da n-o(p-pivaloiloxibenzenossulfonilamino)benzoilglicina e seu produto farmaceuticoInfo
- Publication number
- PT1166773E PT1166773E PT01305556T PT01305556T PT1166773E PT 1166773 E PT1166773 E PT 1166773E PT 01305556 T PT01305556 T PT 01305556T PT 01305556 T PT01305556 T PT 01305556T PT 1166773 E PT1166773 E PT 1166773E
- Authority
- PT
- Portugal
- Prior art keywords
- pivaloyloxibenzenesulfonylamino
- benzoylglycine
- pharmaceutical product
- hydrate solution
- salt tetra
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000195853 | 2000-06-29 | ||
| JP2000195852 | 2000-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1166773E true PT1166773E (pt) | 2004-05-31 |
Family
ID=26594951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01305556T PT1166773E (pt) | 2000-06-29 | 2001-06-27 | Solucao de tetra-hidrato do sal monossodico da n-o(p-pivaloiloxibenzenossulfonilamino)benzoilglicina e seu produto farmaceutico |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6552082B2 (pt) |
| EP (1) | EP1166773B1 (pt) |
| KR (1) | KR100725076B1 (pt) |
| CN (1) | CN1263736C (pt) |
| AT (1) | ATE259218T1 (pt) |
| AU (1) | AU782838B2 (pt) |
| BR (1) | BR0102604B1 (pt) |
| CA (1) | CA2351273C (pt) |
| DE (1) | DE60101979T2 (pt) |
| DK (1) | DK1166773T3 (pt) |
| ES (1) | ES2215856T3 (pt) |
| HU (1) | HUP0102699A2 (pt) |
| MX (1) | MXPA01006698A (pt) |
| NO (1) | NO330296B1 (pt) |
| NZ (1) | NZ512486A (pt) |
| PT (1) | PT1166773E (pt) |
| RU (1) | RU2272623C2 (pt) |
| TR (1) | TR200400585T4 (pt) |
| TW (1) | TWI246925B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2416600A1 (en) * | 2000-07-24 | 2003-01-20 | Ono Pharmaceutical Co., Ltd. | Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof |
| US20050101633A1 (en) * | 2001-05-17 | 2005-05-12 | Takeharu Tonai | Remedial agent for myelopathic disease |
| TW200519080A (en) * | 2003-10-03 | 2005-06-16 | Ono Pharmaceutical Co | Agent containinf (2R)-2-propyloctanic acid as effective component |
| CA2707484C (en) | 2007-12-04 | 2021-08-10 | Remedy Pharmaceuticals, Inc. | Improved formulations and methods for lyophilization and lyophilates provided thereby |
| KR101247137B1 (ko) * | 2011-03-23 | 2013-04-01 | 주식회사 엠씨켐 | Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법 |
| KR101366706B1 (ko) | 2012-12-06 | 2014-02-24 | 상명대학교서울산학협력단 | Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법 |
| CN104107172B (zh) * | 2013-04-18 | 2017-11-28 | 上海汇伦生命科技有限公司 | 西维来司钠注射用冻干粉的制备方法 |
| CN114681435A (zh) * | 2020-12-31 | 2022-07-01 | 上海汇伦生物科技有限公司 | 吸入用药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0320253A (ja) | 1988-06-13 | 1991-01-29 | Ono Pharmaceut Co Ltd | ピバル酸 ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤 |
| CA1340191C (en) | 1988-06-13 | 1998-12-15 | Katsuhiro Imaki | Derivatives of p-substituted phenyl ester of pivalic acid |
| IT1242642B (it) * | 1990-04-17 | 1994-05-16 | Alfa Wassermann Spa | Formulazioni iniettabili contenenti naproxen sale sodico. |
| JP3020253B2 (ja) | 1990-05-02 | 2000-03-15 | 松下電工株式会社 | 配線器具の取付枠への取付構造 |
| EP0539223A1 (en) | 1991-10-25 | 1993-04-28 | Ono Pharmaceutical Co., Ltd. | Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase |
| JPH05194366A (ja) | 1991-10-25 | 1993-08-03 | Ono Pharmaceut Co Ltd | グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法 |
| JP3193597B2 (ja) | 1995-07-28 | 2001-07-30 | 小野薬品工業株式会社 | グリシン誘導体の製造方法 |
| AU5528299A (en) | 1998-09-15 | 2000-04-03 | Naeja Pharmaceutical Inc. | Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s) |
| AU6870800A (en) * | 1999-09-06 | 2001-04-10 | Ono Pharmaceutical Co. Ltd. | Preventive and therapeutic agents for eye diseases |
-
2001
- 2001-06-18 US US09/882,335 patent/US6552082B2/en not_active Expired - Fee Related
- 2001-06-19 NZ NZ512486A patent/NZ512486A/en not_active IP Right Cessation
- 2001-06-21 TW TW090115094A patent/TWI246925B/zh not_active IP Right Cessation
- 2001-06-22 CA CA2351273A patent/CA2351273C/en not_active Expired - Fee Related
- 2001-06-27 NO NO20013223A patent/NO330296B1/no not_active IP Right Cessation
- 2001-06-27 DK DK01305556T patent/DK1166773T3/da active
- 2001-06-27 ES ES01305556T patent/ES2215856T3/es not_active Expired - Lifetime
- 2001-06-27 DE DE60101979T patent/DE60101979T2/de not_active Expired - Lifetime
- 2001-06-27 KR KR1020010036853A patent/KR100725076B1/ko active IP Right Grant
- 2001-06-27 EP EP01305556A patent/EP1166773B1/en not_active Expired - Lifetime
- 2001-06-27 TR TR2004/00585T patent/TR200400585T4/xx unknown
- 2001-06-27 AT AT01305556T patent/ATE259218T1/de active
- 2001-06-27 PT PT01305556T patent/PT1166773E/pt unknown
- 2001-06-27 AU AU54092/01A patent/AU782838B2/en not_active Ceased
- 2001-06-28 RU RU2001118162/15A patent/RU2272623C2/ru not_active IP Right Cessation
- 2001-06-28 MX MXPA01006698A patent/MXPA01006698A/es active IP Right Grant
- 2001-06-28 BR BRPI0102604-6A patent/BR0102604B1/pt not_active IP Right Cessation
- 2001-06-28 HU HU0102699A patent/HUP0102699A2/hu unknown
- 2001-06-29 CN CNB011254688A patent/CN1263736C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100725076B1 (ko) | 2007-06-08 |
| RU2272623C2 (ru) | 2006-03-27 |
| NO20013223D0 (no) | 2001-06-27 |
| ES2215856T3 (es) | 2004-10-16 |
| DE60101979D1 (de) | 2004-03-18 |
| NO20013223L (no) | 2001-12-31 |
| AU782838B2 (en) | 2005-09-01 |
| NZ512486A (en) | 2001-12-21 |
| KR20020002242A (ko) | 2002-01-09 |
| US20020022738A1 (en) | 2002-02-21 |
| BR0102604A (pt) | 2002-02-13 |
| CA2351273A1 (en) | 2001-12-29 |
| TR200400585T4 (tr) | 2004-04-21 |
| CN1263736C (zh) | 2006-07-12 |
| BR0102604B1 (pt) | 2012-06-26 |
| CN1341591A (zh) | 2002-03-27 |
| DE60101979T2 (de) | 2005-01-05 |
| AU5409201A (en) | 2002-03-28 |
| CA2351273C (en) | 2010-09-07 |
| MXPA01006698A (es) | 2004-07-30 |
| US6552082B2 (en) | 2003-04-22 |
| HU0102699D0 (en) | 2001-08-28 |
| NO330296B1 (no) | 2011-03-21 |
| TWI246925B (en) | 2006-01-11 |
| DK1166773T3 (da) | 2004-06-07 |
| ATE259218T1 (de) | 2004-02-15 |
| EP1166773A1 (en) | 2002-01-02 |
| HUP0102699A2 (en) | 2002-06-29 |
| EP1166773B1 (en) | 2004-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0108374B8 (pt) | derivado de pirazina ou um sal deste e composição farmacêutica | |
| CY1106801T1 (el) | Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα | |
| PT848004E (pt) | Derivados pirrolidina tendo actividade inibidora da fosfolipase a2 | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| BR9913097B1 (pt) | Derivado heterocíclico de carboxamida contendo nitrogênio ou um sal do mesmo | |
| ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
| ES2182852T3 (es) | Derivados de prolinamida. | |
| ME00443B (me) | Kristalni oblik tercijalne butilaminske soli perindoprila | |
| SV1999000194A (es) | Preparado farmaceuticio de moxifloxacina ref. lea 33327-sv | |
| EP1018514A4 (en) | NF- $ g (k) B INHIBITORS CONTAINING INDANE DERIVATIVES AS ACTIVE INGREDIENT | |
| DE122010000034I2 (de) | Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| PT1166773E (pt) | Solucao de tetra-hidrato do sal monossodico da n-o(p-pivaloiloxibenzenossulfonilamino)benzoilglicina e seu produto farmaceutico | |
| EE04552B1 (et) | Naatriumalendronaadi hdraadivormid, nende valmistamismeetodid ja neid sisaldavadfarmatseutilised kompositsioonid | |
| TR200403436T2 (tr) | Kristalin 1-metilkarbapenem türevleri. | |
| EA200401090A1 (ru) | Композиция на основе диклофенака для местного лечения заболеваний орофарингеальной полости | |
| BR9708280A (pt) | Compostos de inclusão de diclofenaco/gama-cd | |
| YU81502A (sh) | Ciklopostini, postupak za njihovu proizvodnju i njihova primena | |
| DE69627519D1 (de) | Sesquiterpen-derivate mit antiviraler aktivität | |
| TW375525B (en) | Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives | |
| YU43499A (sh) | Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline | |
| DE60114641D1 (de) | Herstellung von n-geschützten-3-pyrrolidin-lactam substituierten phosphonium salzen | |
| DK0998464T3 (da) | Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser | |
| DK1097145T3 (da) | Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater | |
| BG103923A (en) | Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence | |
| IL160162A0 (en) | Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives |